|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash and cash equivalents | ||||||||||
| Restricted Cash | ||||||||||
| Accounts receivable from third parties | ||||||||||
| Receivables from related parties | ||||||||||
| Inventories | ||||||||||
| Contract fulfillment costs | ||||||||||
| Prepaid expenses and other current assets | ||||||||||
| Total current assets | ||||||||||
| Non-current assets | ||||||||||
| Vessels, net | ||||||||||
| Equity investment | ||||||||||
| Assets held for sale | ||||||||||
| Deferred financing cost, net | ||||||||||
| Vessels under construction | ||||||||||
| Intangible assets | ||||||||||
| Other assets | ||||||||||
| Due from related parties | ||||||||||
| Total non-current assets | ||||||||||
| Total assets | ||||||||||
| Liabilities and shareholders’ equity | ||||||||||
| Current liabilities | ||||||||||
| Bank loans, net | ||||||||||
| Finance Lease, Liability, Current | ||||||||||
| Contract liabilities | ||||||||||
| Taxes Payable | ||||||||||
| Corporate income tax payable | ||||||||||
| Accounts payable and accrued expenses | ||||||||||
| Due to related parties | ||||||||||
| Total current liabilities | ||||||||||
| Non-current liabilities | ||||||||||
| Bank loans, net | ||||||||||
| Capital Lease Obligations, Noncurrent | ||||||||||
| Financing obligation | ||||||||||
| Redeemable notes, related party | ||||||||||
| Other liabilities | ||||||||||
| Total non-current liabilities | ||||||||||
| Total liabilities | ||||||||||
| Preferred stock, shares authorized (in shares) | ||||||||||
| Shareholders’ equity | ||||||||||
| Preferred shares, $0.01 par value per share; 50,000,000 shares authorized; no shares issued or outstanding | ||||||||||
| Common shares, $0.01 par value per share; authorized 81,875,000 and 81,875,000 shares as of December 31, 2022 and 2021, respectively; outstanding 38,446,394 shares and 39,741,204 shares as of December 31, 2022 and 2021 respectively | ||||||||||
| Paid-in capital | ||||||||||
| Treasury Stock, Value | ||||||||||
| Common shares held in treasury, at cost; 2,328,179 shares and 35,869 shares at December 31, 2022 and 2021, respectively | ||||||||||
| Accumulated deficit | ||||||||||
| Total shareholders’ equity | ||||||||||
| Total liabilities and shareholders’ equity | ||||||||||
| Preferred Stock, Par or Stated Value Per Share | ||||||||||
| Common Stock, Shares, Outstanding | ||||||||||
Loading...
